Not logged in Share Save
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers Uhlik, Mark; Pointing, Daniel; Iyer, Seema; Ausec, Luka; Stajdohar, Miha; Cvitkovic, Robert; Zganec, Matjaz; Culm, Kerry; Santos, Valerie Chamberlain; Pytowski, Bronislaw; Malafa, Mokenge; Liu, Hong; Krieg, Arthur M.; Lee, Jeeyun; Rosengarten, Rafael; Benjamin, Laura Share Save
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC Negrao, Marcelo, V; Papadimitrakopoulou, Vassiliki A.; Price, Andrew C.; Tam, Alda L.; Furqan, Muhammad; Laroia, Sandeep T.; Massarelli, Erminia; Pacheco, Jose; Heymach, John, V; Tsao, Anne S.; Walker, Gary, V; Vora, Lalit; Mauro, David; Kelley, Heather; Wooldridge, James E.; Krieg, Arthur M.; Niu, Jiaxin Share Save
Share Save
NEOADJUVANT VIDUTOLIMOD (VIDU) AND NIVOLUMAB (NIVO) RESULTS IN MPR AND IMMUNE ACTIVATION IN HIGH-RISK RESECTABLE MELANOMA (MEL): FINAL PHASE II CLINICAL TRIAL RESULTS Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Morrison, Robert; Bai, Yulong; Sun, Jie; Wang, Hong; Hartman, Douglas; Stein, Julie; Deitrick, Christopher; Bao, Riyue; Singh, Jagjit; Ding, Quanquan; Gao, Wentao; Hurd, Drew; Pagliano, Ornella; Rose, Amy; Najjar, Yana; Luke, Jason; Mauro, David; Krieg, Arthur; Wooldridge, James; Bobilev, Dmitri; Kirkwood, John; Taube, Janis; Park, Hyun Jung; Zarour, Hassane; Davar, Diwakar Share Save
FINAL ANALYSIS: PHASE 1B STUDY INVESTIGATING INTRATUMORAL INJECTION OF TOLL-LIKE RECEPTOR 9 AGONIST VIDUTOLIMOD ± PEMBROLIZUMAB IN PATIENTS WITH PD-1 BLOCKADE-REFRACTORY MELANOMA Kirkwood, John; Zakharia, Yousef; Davar, Diwakar; Buchbinder, Elizabeth; Medina, Theresa; Daud, Adil; Ribas, Antoni; Chmielowski, Bartosz; Niu, Jiaxin; Gibney, Geoffrey; Margolin, Kim; Olszanski, Anthony; Mehmi, Inderjit; Sato, Takami; Shaheen, Montaser; Zhao, Luping; Liu, Hong; Kelley, Heather; Weiner, George; Luke, Jason; Bobilev, Dmitri; Krieg, Arthur; Wooldridge, James; Milhem, Mohammed Share Save
Share Save
INTRATUMORAL INJECTION OF CMP-001, A TOLL-LIKE RECEPTOR 9 (TLR9) AGONIST, IN COMBINATION WITH PEMBROLIZUMAB REVERSED PROGRAMMED DEATH RECEPTOR 1 (PD-1) BLOCKADE RESISTANCE IN ADVANCED MELANOMA Milhem, Mohammed; Zakharia, Yousef; Davar, Diwakar; Buchbinder, Elizabeth; Medina, Theresa; Daud, Adil; Ribas, Antoni; Niu, Jiaxin; Gibney, Geoffrey; Margolin, Kim; Olszanski, Anthony; Mehmi, Inderjit; Sato, Takami; Shaheen, Montaser; Morris, Aaron; Mauro, David; Campbell, Katie; Kelley, Heather; Bao, Riyue; Weiner, George; Luke, Jason; Krieg, Arthur; Wooldridge, James; Kirkwood, John Share Save
DURABLE RESPONSES IN ANTI-PD-1 REFRACTORY MELANOMA FOLLOWING INTRATUMORAL INJECTION OF A TOLL-LIKE RECEPTOR 9 (TLR9) AGONIST, CMP-001, IN COMBINATION WITH PEMBROLIZUMAB Milhem, Mohammed; Zakharia, Yousef; Davar, Diwakar; Buchbinder, Elizabeth; Medina, Theresa; Daud, Adil; Ribas, Antoni; Niu, Jiaxin; Gibney, Geoffrey; Margolin, Kim; Olszanski, Anthony; Mehmi, Interjit; Sato, Takami; Shaheen, Montaser; Morris, Aaron; Mauro, David; Campbell, Katie; Bao, Riyue; Weiner, George; Luke, Jason; Krieg, Arthur; Kirkwood, John Share Save
Share Save
Share Save
Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma Milhem, Mohammed; Gonzales, Rene; Medina, Theresa; Kirkwood, John M.; Buchbinder, Elizabeth; Mehmi, Inderjit; Niu, Jiaxin; Shaheen, Montaser; Weight, Ryan; Margolin, Kim; Luke, Jason; Morris, Aaron; Mauro, David; Krieg, Arthur M.; Ribas, Antoni Share Save
Share Save
Share Save
Share Save
Share Save
PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines Fourcade, Julien; Sun, Zhaojun; Pagliano, Ornella; Chauvin, Joe-Marc; Sander, Cindy; Janjic, Bratislav; Tarhini, Ahmad A.; Tawbi, Hussein A.; Kirkwood, John M.; Moschos, Stergios; Wang, Hong; Guillaume, Philippe; Luescher, Immanuel F.; Krieg, Arthur; Anderson, Ana C.; Kuchroo, Vijay K.; Zarour, Hassane M. Share Save
Share Save
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery Nguyen, David N.; Mahon, Kerry P.; Chikh, Ghania; Kim, Phillip; Chung, Hattie; Vicari, Alain P.; Love, Kevin T.; Goldberg, Michael; Chen, Steve; Krieg, Arthur M.; Chen, Jianzhu; Langer, Robert; Anderson, Daniel G. Share Save
Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant La Rosa, Corinna; Longmate, Jeff; Lacey, Simon F.; Kaltcheva, Teodora; Sharan, Rahul; Marsano, Denise; Kwon, Peter; Drake, Jennifer; Williams, Brenda; Denison, Sharon; Broyer, Suenell; Couture, Larry; Nakamura, Ryotaro; Kelsey, Morris I.; Krieg, Arthur M.; Diamond, Don J.; Zaia, John A. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
